Provided by Tiger Trade Technology Pte. Ltd.

Omnicell

32.75
-2.4500-6.96%
Post-market: 32.750.00000.00%19:19 EDT
Volume:443.35K
Turnover:14.69M
Market Cap:1.49B
PE:725.16
High:34.72
Open:34.66
Low:32.69
Close:35.20
52wk High:55.00
52wk Low:22.66
Shares:45.44M
Float Shares:44.35M
Volume Ratio:0.80
T/O Rate:1.00%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0452
EPS(LYR):0.0400
ROE:0.17%
ROA:0.36%
PB:1.21
PE(LYR):818.75

Loading ...

BRIEF-Omnicell Q4 Revenue USD 314 Million

Reuters
·
Feb 05

Omnicell - Outlook FY Adj EPS $1.65 - $1.85

THOMSON REUTERS
·
Feb 05

Omnicell - Outlook FY Total Revenues $1.215 Billion - $1.255 Billion

THOMSON REUTERS
·
Feb 05

Omnicell Announces Fiscal Year and Fourth Quarter 2025 Financial Results

THOMSON REUTERS
·
Feb 05

Omnicell management to meet with Piper Sandler

TIPRANKS
·
Feb 05

BofA Upgrades Omnicell to Buy From Neutral

MT Newswires Live
·
Feb 04

Omnicell upgraded to Buy from Neutral at BofA

TIPRANKS
·
Feb 04

Is Omnicell (OMCL) Starting To Look Interesting After Recent Share Price Swings?

Simply Wall St.
·
Feb 04

Omnicell Is Maintained at Buy by Benchmark

Dow Jones
·
Feb 02

Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL) and Immunocore Holdings (IMCR)

TIPRANKS
·
Feb 02

Earning Preview: Omnicell’s revenue is expected to increase by 4.60%, and institutional views are bullish

Earnings Agent
·
Jan 29

Omnicell XT Amplify Launch Highlights Digital Health Role And Rich Valuation

Simply Wall St.
·
Jan 25

Omnicell XT Amplify Puts Medication Management And Growth Story To Test

Simply Wall St.
·
Jan 24

Press Release: Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026

Dow Jones
·
Jan 13

Omnicell Inc. to Release Fourth Quarter and Full Year 2025 Financial Results

Reuters
·
Jan 13

Omnicell Shares Rise After KeyBanc Upgrade

MT Newswires Live
·
Jan 09

KeyBanc Upgrades Omnicell to Overweight From Sector Weight, $60 Price Target

MT Newswires Live
·
Jan 08

Omnicell Raised to Overweight From Sector Weight by Keybanc

Dow Jones
·
Jan 08

Omnicell Is Maintained at Overweight by Wells Fargo

Dow Jones
·
Jan 06

Omnicell (OMCL) valuation check as new Titan XT automation platform targets healthcare growth

Simply Wall St.
·
Dec 23, 2025